Erythroleukemia: A comparison between the previous FAB approach and the WHO classification

Leukemia Research

Volumn 26, Issue 5, 2002, Pages 423-429

  Park, Sophie ^a   Picard, Françoise ^a   Azgui, Zahia ^b   Viguie, Franck ^c   Merlat, Annabelle ^a   Guesnu, Martine ^a   Leblond, Véronique ^b   Dreyfus, François ^a  

^a Hôpital Cochin ^*  (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔTEL DIEU   (France)

Author keywords

Acute myeloid leukemia 6 variant; Erythroleukemia; FAB classification; Myelodysplasia; WHO classification

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; BLAST CELL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; CYTOPATHOLOGY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ERYTHROBLAST; ERYTHROLEUKEMIA; FEMALE; HUMAN; KARYOTYPE; MALE; MYELOBLAST; PRIORITY JOURNAL; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MIDDLE AGED; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

EID: 0036204349     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00146-1     Document Type: Article

References (21)

1. Phenotype of early erythroblastic leukemias
2. Minimally differentiated erythroleukemia ('AML6′ variant'): A rare subset of AML distinct from AML6
3. 1985 proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
4. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia
5. The prognostic significance of proerythroblasts in acute erythroleukemia
6. International scoring system for evaluating prognosis in myelodysplastic syndromes
7. Non-parametric estimation from incomplete observations
8. Erythroleukemia: A study of 15 cases and literature review
9. Erythroleukemia: A review of 15 cases meeting 1985 FAB criteria and survey of the literature
10. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): A CALGB study
11. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases
12. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia (AML)) on outcome of AML-type chemotherapy
13. Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French-American-British (FAB) co-operative group criteria
14. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: An EBMT survey
15. Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: A long-term study of 71 patients
16. Bone marrow transplantation for therapy-related myelodysplasia: Comparison with primary myelodysplasia
17. Medical and laboratory features of de novo acute myeloid leukemia with trilineage myelodysplasia
18. Myelodysplastic relapse of de novo acute myeloid leukemia with trilineage myelodysplasia: A previously unrecognized correlation
19. Long-term follow-up of de novo myelodysplastic syndromes treated with intensive chemotherapy: Incidence of long-term survivors and outcome of partial responders
20. Treatment of advanced primary myelodysplastic syndromes with AML-type chemotherapy: Results in 76 patients
21. Acute erythremic myelosis (true erythroleukemia): A variant of AML-FAB-M6